Treatment of long bone non-unions with polytherapy: indications and clinical results.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21524745.
- Also identified by DOI 10.1016/j.injury.2011.03.046.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The incidence of long bone non-unions has been estimated to range between 5 and 10%. Autologous bone graft usually harvested from the iliac crest continues to be the gold standard for biological enhancement of atrophic non-unions. However, its use has been hampered by minor and major donor site complications. Moreover despite possessing the properties of osteogenecity, osteoconductivity and some osteoinductivity the overall results of treatment have not been consistent with disappointing success rates at times. The concept of polytherapy for the treatment of non-unions, namely the simultaneous application of the three fundamental elements of the diamond concept, osteoprogenitor cells, growth factor and osteoconductive scaffold, appears to be an attractive alternative but more studies are desirable to validate this strategy.
Medical subject headings
- Bone Morphogenetic Proteins
- Bone Transplantation
- Fracture Healing
- Fractures, Ununited
- Mesenchymal Stem Cell Transplantation
- Tissue Scaffolds